Home » Stocks » BioTelemetry

BioTelemetry, Inc. (BEAT)

Stock Price: $43.47 USD 1.32 (3.13%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.49B
Revenue (ttm) 435.47M
Net Income (ttm) 19.25M
Shares Out 34.19M
EPS (ttm) 0.53
PE Ratio 82.02
Forward PE 20.16
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $43.47
Previous Close $42.15
Change ($) 1.32
Change (%) 3.13%
Day's Open 42.25
Day's Range 42.02 - 43.66
Day's Volume 183,182
52-Week Range 27.35 - 55.85

More Stats

Market Cap 1.49B
Enterprise Value 1.56B
Earnings Date (est) Oct 29, 2020
Ex-Dividend Date n/a
Shares Outstanding 34.19M
Float 33.08M
EPS (basic) 0.57
EPS (diluted) 0.53
FCF / Share 2.02
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.22%
FCF Yield 4.66%
Payout Ratio n/a
Shares Short 3.90M
Short Ratio 8.99
Short % of Float 11.79%
Beta 1.14
PE Ratio 82.02
Forward PE 20.16
P/FCF Ratio 21.46
PS Ratio 3.41
PB Ratio 3.75
Revenue 435.47M
Operating Income 43.41M
Net Income 19.25M
Free Cash Flow 69.24M
Net Cash -74.13M
Net Cash / Share -2.17
Gross Margin 61.28%
Operating Margin 9.97%
Profit Margin 4.40%
FCF Margin 15.90%
ROA 5.14%
ROE 5.27%
ROIC 12.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (7)

Buy 5
Overweight 0
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$54.33*
(24.98% upside)
Low
43.0
Current: $43.47
High
61.0
Target: 54.33
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue439399287208179167130111119120
Revenue Growth9.92%39.3%37.65%16.7%7.16%28.63%16.15%-6.32%-0.75%-
Gross Profit27425017212910793.4679.0765.9069.9572.43
Operating Income52.7549.81-1.7618.019.52-4.31-6.88-13.16-61.32-19.69
Net Income29.8442.82-15.9653.447.43-9.79-7.32-12.20-61.42-19.86
Shares Outstanding33.9532.7130.3927.9227.1226.4425.5424.9324.4324.11
Earnings Per Share0.821.20-0.531.750.26-0.37-0.29-0.49-2.51-0.82
EPS Growth-31.67%--573.08%------
Operating Cash Flow67.5572.7523.7838.8514.358.8111.265.745.0310.36
Capital Expenditures-30.71-24.64-13.70-10.90-13.60-12.78-8.17-5.96-3.95-5.25
Free Cash Flow36.8448.1110.0927.950.75-3.973.09-0.221.085.12
Cash & Equivalents68.6180.8936.0223.0518.9920.0122.1518.3046.4845.48
Total Debt19520020525.4523.5824.740.66---
Net Cash / Debt-127-119-169-2.40-4.60-4.7321.5018.3046.4845.48
Assets68658752519912412487.5590.0194.98157
Liabilities31927627560.0748.2260.7020.7220.0116.9821.76
Book Value36731025113975.9363.6866.8370.0078.00135
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name BioTelemetry, Inc.
Country United States
Employees 1,700
CEO Joseph H. Capper

Stock Information

Ticker Symbol BEAT
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: BEAT
IPO Date March 18, 2008

Description

BioTelemetry, a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.